Toward an understanding of NKT cell biology: Progress and paradoxes

被引:822
作者
Kronenberg, M [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA
关键词
T cell; natural killer; CD1d; glycolipid;
D O I
10.1146/annurev.immunol.23.021704.115742
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer T (NKT) cells constitute a conserved T cell sublineage with unique properties, including reactivity for a synthetic glycolipid presented by CD1d, expression of an invariant T cell antigen receptor (TCR) alpha chain, and unusual requirements for thymic selection. They rapidly produce many cytokines after stimulation and thus influence diverse immune responses and pathogenic processes. Because of intensive research effort, we have learned much about factors promoting the development and survival of NKT cells, regulation of their cytokine production, and the means by which they influence dendritic cells and other cell types. Despite this progress, knowledge of the natural antigen(s) they recognize and their physiologic role remain incomplete. The activation of NKT cells paradoxically can lead either to suppression or stimulation of immune responses, and we cannot predict which will occur. Despite this uncertainty, many investigators are hopeful that immune therapies can be developed based on NKT cell stimulation.
引用
收藏
页码:877 / 900
页数:24
相关论文
共 159 条
  • [1] Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity
    Akbari, O
    Stock, P
    Meyer, E
    Kronenberg, M
    Sidobre, S
    Nakayama, T
    Taniguchi, M
    Grusby, MJ
    DeKruyff, RH
    Umetsu, DT
    [J]. NATURE MEDICINE, 2003, 9 (05) : 582 - 588
  • [2] Evidence for two subgroups of CD4-CD8- NKT cells with distinct TCRαβ repertoires and differential distribution in lymphoid tissues
    Apostolou, I
    Cumano, A
    Gachelin, G
    Kourilsky, P
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (05) : 2481 - 2490
  • [3] Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission
    Araki, M
    Kondo, T
    Gumperz, JE
    Brenner, MB
    Miyake, S
    Yamamura, T
    [J]. INTERNATIONAL IMMUNOLOGY, 2003, 15 (02) : 279 - 288
  • [4] Interferon gamma production by natural killer (NK) cells and NK1.1(+) T cells upon NKR-P1 cross-linking
    Arase, H
    Arase, N
    Saito, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) : 2391 - 2396
  • [5] Azuma T, 2003, CANCER RES, V63, P4516
  • [6] Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection
    Baron, JL
    Gardiner, L
    Nishimura, S
    Shinkai, K
    Locksley, R
    Ganem, D
    [J]. IMMUNITY, 2002, 16 (04) : 583 - 594
  • [7] The crystal structure of human CD1b with a bound bacterial glycolipid
    Batuwangala, T
    Shepherd, D
    Gadola, SD
    Gibson, KJC
    Zaccai, NR
    Fersht, AR
    Besra, GS
    Cerundolo, V
    Jones, EY
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (04) : 2382 - 2388
  • [8] NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic β cells
    Beaudoin, L
    Laloux, V
    Novak, J
    Lucas, B
    Lehuen, A
    [J]. IMMUNITY, 2002, 17 (06) : 725 - 736
  • [9] Mouse CD1-specific NK1 T cells: Development, specificity, and function
    Bendelac, A
    Rivera, MN
    Park, SH
    Roark, JH
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 535 - 562
  • [10] A SUBSET OF CD4(+) THYMOCYTES SELECTED BY MHC CLASS-I MOLECULES
    BENDELAC, A
    KILLEEN, N
    LITTMAN, DR
    SCHWARTZ, RH
    [J]. SCIENCE, 1994, 263 (5154) : 1774 - 1778